The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Medical Device Clinical Trials Market Across 2026–2030?
The market size for medical device clinical trials has shown strong growth in recent years. It is forecast to increase from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. The expansion observed in the historical period can be attributed to advancements in medical device innovation, strict regulatory approval criteria, a growing need for patient safety validation, the widening scope of hospital-based clinical research, and increased investment in generating clinical evidence.
The medical device clinical trials market is projected to experience substantial expansion over the next few years. This sector is anticipated to reach $25.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This expected growth during the forecast period is primarily driven by factors such as the increasing development of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the broadening of digital trial platforms, greater integration of remote patient monitoring in trials, and the ongoing globalization of clinical studies. Furthermore, prominent trends anticipated during this period include the wider adoption of decentralized clinical trials, a growing reliance on real-world evidence in device evaluations, an increased focus on post-approval and long-term safety investigations, the expansion of adaptive and hybrid trial methodologies, and a rising imperative for regulatory-compliant trial management.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp
What Primary Drivers Are Shaping The Development Of The Medical Device Clinical Trials Market?
The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the medical device clinical trials market in the future. These conditions are defined as long-term health issues that evolve gradually and necessitate continuous medical attention. The surge in chronic diseases is attributed to sedentary lifestyles, where individuals spend extended periods seated at desks or engaging with electronic devices, leading to decreased calorie burning and compromised cardiovascular health, consequently fostering conditions like obesity, diabetes, and hypertension. This escalation in chronic illnesses necessitates medical device clinical trials to create and authenticate innovative devices for accurate diagnosis, effective treatment, and comprehensive management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion individuals worldwide were afflicted with diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the growing prevalence of chronic diseases is a key factor propelling the development of the medical device clinical trials market.
What Segmentation Levels Are Considered In The Medical Device Clinical Trials Market?
The medical device clinical trials market covered in this report is segmented –
1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study
2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications
3) By Study Design: Interventional, Observational, Expanded Access
Subsegments:
1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing
2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials
3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies
4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies
What Trends Are Projected To Affect The Medical Device Clinical Trials Market?
Leading businesses within the medical device clinical trials sector are concentrating on creating AI-enabled medical device software, aiming to streamline clinical trial protocols and resource deployment to boost trial effectiveness and lower expenses. This AI-driven medical device software encompasses applications in healthcare that utilize artificial intelligence (AI) algorithms, particularly machine learning or deep learning, either to assist with or to automate various medical responsibilities. As an illustration, in January 2025, Risklick, a pharmaceutical firm located in Switzerland, introduced Protocol AI, an AI-driven software solution intended to expedite and refine clinical trials specifically for medical devices. Protocol AI employs Natural Language Processing (NLP) and Machine Learning (ML) capabilities to examine clinical data, published works, and regulatory paperwork, generating drafts of clinical trial protocols automatically within minutes. This groundbreaking tool substantially cuts down the time and expenditures associated with protocol creation, a process that typically spans approximately six months, and it has already achieved up to a 50% decrease in document development duration for medicinal products.
Which Leading Firms Are Contributing To The Growth Of The Medical Device Clinical Trials Market?
Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG
Read the full medical device clinical trials market report here:
How Does The Medical Device Clinical Trials Market Perform Across Major Global Regions?
North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Medical Device Clinical Trials Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp
Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company
Clinical Trial Supplies Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report
Virtual Clinical Trials Market Report 2026
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report
Medical Device Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model